O'Shares Investment Advisers, LLC Gilead Sciences, Inc. Transaction History

O'Shares Investment Advisers, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$57.72 - $65.01 $7.06 Million - $7.95 Million	-122,288 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $395,535 - $495,648	6,829 Added 5.91%	122,288 $7.27 Million
Q4 2021 Feb 02, 2022	BUY	$64.88 - $73.64 $544,343 - $617,839	8,390 Added 7.84%	115,459 $8.38 Million
Q3 2021 Nov 05, 2021	BUY	$67.69 - $73.03 $7.25 Million - $7.82 Million	107,069 New	107,069 $7.48 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $1.42 Million - $1.79 Million	-22,868 Closed	0 $0

Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $3.04 Million - $3.53 Million	-42,063 Reduced 64.78%	22,868 $1.76 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $3,382 - $4,331	-54 Reduced 0.08%	64,931 $4.85 Million
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $260,344 - $286,370	4,225 Added 6.95%	64,985 $4.22 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $3.8 Million - $4.19 Million	60,760 New	60,760 $3.85 Million

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of O'Shares Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shares Investment Advisers, LLC with notifications on news.